These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Podometrics in Japanese Living Donor Kidneys: Associations with Nephron Number, Age, and Hypertension. Haruhara K; Sasaki T; de Zoysa N; Okabayashi Y; Kanzaki G; Yamamoto I; Harper IS; Puelles VG; Shimizu A; Cullen-McEwen LA; Tsuboi N; Yokoo T; Bertram JF J Am Soc Nephrol; 2021 May; 32(5):1187-1199. PubMed ID: 33627345 [TBL] [Abstract][Full Text] [Related]
4. Nephron deficit and low podocyte density increase risk of albuminuria and glomerulosclerosis in a model of diabetes. Gazzard SE; van der Wolde J; Haruhara K; Bertram JF; Cullen-McEwen LA Physiol Rep; 2023 Jan; 11(2):e15579. PubMed ID: 36695822 [TBL] [Abstract][Full Text] [Related]
5. Questioning the renoprotective role of L-type calcium channel blockers in chronic kidney disease using physiological modeling. Moore KH; Clemmer JS Am J Physiol Renal Physiol; 2021 Oct; 321(4):F548-F557. PubMed ID: 34486399 [TBL] [Abstract][Full Text] [Related]
7. Associations between nephron number and podometrics in human kidneys. Haruhara K; Kanzaki G; Sasaki T; Hatanaka S; Okabayashi Y; Puelles VG; Harper IS; Shimizu A; Cullen-McEwen LA; Tsuboi N; Yokoo T; Bertram JF Kidney Int; 2022 Nov; 102(5):1127-1135. PubMed ID: 36175177 [TBL] [Abstract][Full Text] [Related]
8. AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Canaud G; Bienaimé F; Viau A; Treins C; Baron W; Nguyen C; Burtin M; Berissi S; Giannakakis K; Muda AO; Zschiedrich S; Huber TB; Friedlander G; Legendre C; Pontoglio M; Pende M; Terzi F Nat Med; 2013 Oct; 19(10):1288-96. PubMed ID: 24056770 [TBL] [Abstract][Full Text] [Related]
9. Factors associated with a vicious cycle involving a low nephron number, hypertension and chronic kidney disease. Kanzaki G; Tsuboi N; Haruhara K; Koike K; Ogura M; Shimizu A; Yokoo T Hypertens Res; 2015 Oct; 38(10):633-41. PubMed ID: 26084263 [TBL] [Abstract][Full Text] [Related]
10. Nephron overload as a therapeutic target to maximize kidney lifespan. Luyckx VA; Rule AD; Tuttle KR; Delanaye P; Liapis H; Gandjour A; Romagnani P; Anders HJ Nat Rev Nephrol; 2022 Mar; 18(3):171-183. PubMed ID: 34880459 [TBL] [Abstract][Full Text] [Related]
11. Nephron number, hypertension, and CKD: physiological and genetic insight from humans and animal models. Wang X; Garrett MR Physiol Genomics; 2017 Mar; 49(3):180-192. PubMed ID: 28130427 [TBL] [Abstract][Full Text] [Related]
12. Postnatal podocyte gain: Is the jury still out? Puelles VG; Moeller MJ Semin Cell Dev Biol; 2019 Jul; 91():147-152. PubMed ID: 31178004 [TBL] [Abstract][Full Text] [Related]
13. Changing Protein Permeability with Nephron Loss: Evidence for a Human Remnant Nephron Effect. Willows J; Odudu A; Logan I; Sheerin N; Tomson C; Ellam T Am J Nephrol; 2019; 50(2):152-159. PubMed ID: 31269482 [TBL] [Abstract][Full Text] [Related]
14. Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate. Lane BR; Demirjian S; Derweesh IH; Takagi T; Zhang Z; Velet L; Ercole CE; Fergany AF; Campbell SC Eur Urol; 2015 Dec; 68(6):996-1003. PubMed ID: 26012710 [TBL] [Abstract][Full Text] [Related]
15. Hypertension control and antihypertensive therapy in patients with chronic kidney disease. Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796 [TBL] [Abstract][Full Text] [Related]
16. Educational paper: Progression in chronic kidney disease and prevention strategies. Schaefer B; Wühl E Eur J Pediatr; 2012 Nov; 171(11):1579-88. PubMed ID: 22968936 [TBL] [Abstract][Full Text] [Related]